Synthetic opioid production in Europe with Paul Griffiths
Addiction Audio4 Huhti 2024

Synthetic opioid production in Europe with Paul Griffiths

In this episode, Dr Elle Wadsworth talks to Paul Griffiths about synthetic drug production in Europe including the differences between lab-made substances and diverted medical drugs. They discuss organised crime and its impact on cocaine production, drug availability and the potential for drug contamination. They also cover fentanyl and the potential for a heroin drought resulting from changes in opium production in Afghanistan.


Paul talks about the complexities of European drug markets explaining how they commonly respond to changes in both supply and demand. Elle and Paul then discuss how researchers can monitor drug trends through wastewater analysis and other methods.


“These are often very small labs, but because of the potency of these drugs, it means very small production runs can have quite a big impact on local drug consumption patterns and mortality and morbidity. So we saw a few years ago, ten or fifteen years, one lab in central Europe we had a very brief outbreak of deaths in about three countries all related to a very very small, a kitchen lab it was actually in someone’s kitchen but it had an impact.”


Paul Griffiths is the scientific director for the EMCDDA – the European Monitoring Centre for Drugs and Drug Addiction


Original article: Opioid problems are changing in Europe with worrying signals that synthetic opioids may play a more significant role in the future by Paul Griffiths and colleagues. Published in Addiction (2024)


The opinions expressed in this post reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.

The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.

Hosted on Acast. See acast.com/privacy for more information.

Jaksot(115)

Hallucinogen use, young adults and monitoring the future with Katherine Keyes

Hallucinogen use, young adults and monitoring the future with Katherine Keyes

In this episode, Dr Elle Wadsworth talks to Dr Katherine Keyes about her study examining changes to hallucinogen use among young adults in the US. Katherine also talks about using the Monitoring The F...

3 Elo 202323min

Perspectives on gambling from 1561 with Louise Nadeau

Perspectives on gambling from 1561 with Louise Nadeau

In this episode Ben Scher talks to Professor Louise Nadeau about her recent article anaysing the content of a Latin-language treatise on gambling addiction written nearly 500 years ago. Ben and Louise...

28 Heinä 202323min

Risk of bias in tobacco cessation trials with Jamie Hartmann-Boyce

Risk of bias in tobacco cessation trials with Jamie Hartmann-Boyce

In this episode, Chloe Burke talks to Dr Jamie Hartmann-Boyce about new guidance from the Cochrane Tobacco Addiction Group (TAG) on assessing and minimising risk of bias in tobacco cessation trials. J...

20 Heinä 202320min

Cannabis legalisation in Canada with Janni Leung

Cannabis legalisation in Canada with Janni Leung

In this episode, Dr Elle Wadsworth talks to Dr Janni Leung about her work on a systematic review of the evidence on cannabis arrests, cannabis products and prices since Canada legalised cannabis. Jann...

13 Heinä 202325min

Bacterial infections and social determinants of health with Thomas Brothers

Bacterial infections and social determinants of health with Thomas Brothers

In this episode Ben Scher talks to Dr Thomas Brothers about his qualitative systematic review looking at infections from injecting drug use. Tommy and Ben talk about bacterial and fungal infections an...

12 Heinä 202321min

Cannabis and apps with Marleen Olthof and Matthijs Blankers

Cannabis and apps with Marleen Olthof and Matthijs Blankers

In this episode, Rob Calder talks to Marleen Olthof and Dr Matthijs Blankers about their research into ICan - a digital health app designed to reduce cannabis use. They initially talk about the potent...

29 Kesä 202330min

Long-acting buprenorphine with Jo Neale

Long-acting buprenorphine with Jo Neale

Professor Joanne Neale talks to Addiction Audio about her latest research into how people feel during the first 72 hours of having long-acting buprenorphine (Buvidal). Jo talks about the recent histor...

8 Kesä 202325min

Smoking and Ecological Momentary Assessment with Olga Perski

Smoking and Ecological Momentary Assessment with Olga Perski

Dr Perski explains the evolution of Ecological Momentry Assessment (EMA) studies and how they have been used to collect granular data relating to everyday experiences. Olga's latest review focuses on ...

10 Touko 202337min

Suosittua kategoriassa Tiede

tiedekulma-podcast
rss-mita-tulisi-tietaa
rss-poliisin-mieli
docemilia
utelias-mieli
radio-antro
filocast-filosofian-perusteet
rss-sosiopodi
ihanat-ipanat
mielipaivakirja
rss-bios-podcast
rss-duodecim-lehti
rss-laakaripodi
rss-radplus
rss-opeklubi
rss-lihavuudesta-podcast